The Journal of organic chemistry

medicinal chemistry (shariqah (united arab emirates))

Antiviral research

[1] Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP).

[2] Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307.

[3] Preliminary anti-Coxsackie activity of novel 1-[4-(5,6-dimethyl(H)-1H(2H)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas.

[4] C-H Imidation and Dual C-H Bond Aminobromination of Five-Membered Heterocycles.

[5] causation of acute flaccid paralysis by myelitis and myositis in enterovirus-d68 infected mice deficient in interferon αβ/γ receptor deficient mice

[6] coxsackievirus b5 associated with hand-foot-mouth disease in a healthy adult

[7] comparison of the prevalence of enteroviruses in blood samples of patients with and without unstable angina

[8] replication and inhibitors of enteroviruses and parechoviruses

[9] Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice.

[10] Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin.

[11] Molecular epidemiological study of enterovirus D68 in hospitalised children in Hong Kong in 2014-2015 and their complete coding sequences.

[12] [Association of interleukin-10 gene polymorphism with enterovirus 71 infection in children].

[13] The History of Enterovirus A71 Outbreaks and Molecular Epidemiology in the Asia-Pacific Region.

[14] α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment

[15] Phylogenetic characteristics and molecular epidemiological analysis of novel enterovirus EV-B83 isolated from Tibet, China

[16] enterovirus no polio de casos con parálisis residual. colombia, 1992-1995

[17] causation of acute flaccid paralysis by myelitis and myositis in enterovirus-d68 infected mice deficient in interferon αβ/γ receptor deficient mice

[18] the antiviral effect of baicalin on enterovirus 71 in vitro

[19] expression of enterovirus 71 capsid protein vp1 in escherichia coli and its clinical application

[20] comparison of the prevalence of enteroviruses in blood samples of patients with and without unstable angina

[21] identification of a common epitope between enterovirus 71 and human med25 proteins which may explain virus-associated neurological disease

[22] evaluation of enterovirus 71 immune status in são paulo state, brazil

[23] replication and inhibitors of enteroviruses and parechoviruses

[24] antiviral and inflammatory cellular signaling associated with enterovirus 71 infection

[25] increased frequency of circulating follicular helper t cells in children with hand, foot, and mouth disease caused by enterovirus 71 infection